Ivabradine in cardiogenic shock with catecholamine weaning failure: focus on the atrial fibrillation subpopulation

28 August 2026 (14:15 - 14:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Selma Charfeddine

Hedi Chaker hospital, Sfax (Tunisia)

3 More presentations in this session

Presentation thumbnail

Biopsy-proven myocarditis in the intensive care unit: diagnostic and prognostic insights from a monocentric cohort

Doctor A. Giordani (Padova, IT)

Abstract Slides Video

Presentation thumbnail

Ivabradine for hemodynamic optimization and catecholamine weaning in cardiogenic shock: a retrospective cohort study

Associate Professor S. Charfeddine (Sfax, TN)

Abstract Slides Video

Presentation thumbnail

Clinical characteristics and prognostic impact of complicated phenotype in patients with acute myocarditis: a single-center registry study in china

Miss J. Wang (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

New insights into myocarditis and shock

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET

You may be interested in

Congress Presentation

Differences in short- and long-term prognostic determinants according to etiology in cardiogenic shock

29 August 2026

Congress Presentation

Ivabradine-associated atrial fibrillation: proarrhythmic effect or enhanced detection? A combined meta-analysis and FAERS disproportionality analysis

12 April 2026

Congress Presentation

Medical therapy: the unmet needs

12 May 2024

Congress Presentation

Utilization and safety of digoxin in patients with chronic heart failure and atrial fibrillation with rapid ventricular rate

30 August 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources